These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8055786)

  • 41. [Changes in human growth hormone secretion in uremia].
    Pascual JM; Rovira A; Ghiglione M; Casado S; Valverde I
    Rev Clin Esp; 1982 Dec; 167(6):381-4. PubMed ID: 6820532
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of many years of hemodialysis therapy on FSH secretion induced by luliberin in men with chronic renal failure].
    Starzyk J; Grzeszczak W; Kowalski D
    Wiad Lek; 1993 Apr; 46(7-8):286-91. PubMed ID: 8249417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Serum levels of thyroxine (T4), triiodothyronine (T3) and thyrotropic hormone (TSH) in chronic kidney insufficiency].
    Mushmov D; Zakharieva B; Patev E; Kiriakov Z
    Vutr Boles; 1980; 19(2):68-75. PubMed ID: 7385804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential microvasculature dysfunction in living kidney donor transplant recipients: nondialyzed versus dialyzed chronic kidney disease patients.
    Chung AW; Yang HH; Sigrist MK; Chum E; Booth AD; Gourlay WA; Levin A
    J Vasc Res; 2010; 47(2):128-38. PubMed ID: 19729959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Influence of hemodialysis, heparin and protamin on the pre-beta fraction of lipoproteins in patients with chronic kidney failure].
    Koslík S; Takác M; Koslíkova G
    Z Gesamte Inn Med; 1977 Dec; 32(23):658-61. PubMed ID: 204117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Retinal oscillatory potentials in the study of retinopathy in dialyzed subjects with chronic renal insufficiency].
    Lazzarino LG; De Grandis D; Pitzorno F; Polo A
    Riv Neurol; 1990; 60(3):103-7. PubMed ID: 2084813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum levels of polyamines in patients with chronic renal failure.
    Saito A; Takagi T; Chung TG; Ohta K
    Kidney Int Suppl; 1983 Dec; 16():S234-7. PubMed ID: 6588257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Circadian rhythm of pituitary-thyroid hormones in patients with chronic renal failure treated by hemodialysis].
    Grzeszczak W; Zukowska-Szczechowska E
    Pol Arch Med Wewn; 1994; 92 Spec No():21-30. PubMed ID: 7731896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Counterregulatory hormonal response to insulin-induced hypoglycemia in patients on chronic hemodialysis.
    Ramirez G; Brueggemeyer C; Ganguly A
    Nephron; 1988; 49(3):231-6. PubMed ID: 2840587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of hemodialysis on glucose tolerance in children with chronic renal failure.
    Parra A; Lopez-Uriarte A; Argote RM; Garcia G; Ledón S; Santos D
    Arch Invest Med (Mex); 1979; 10(2):39-52. PubMed ID: 475539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemodialysis-induced hypoglycemia in diabetic patients.
    Jackson MA; Holland MR; Nicholas J; Lodwick R; Forster D; Macdonald IA
    Clin Nephrol; 2000 Jul; 54(1):30-4. PubMed ID: 10939754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased melatonin nocturnal concentrations in hemodialyzed patients.
    Karasek M; Szuflet A; Chrzanowski W; Zylinska K; Swietoslawski J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):653-6. PubMed ID: 16380697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcitonin secretion in chronic renal patients treated with hemodialysis.
    Gozariu L; Manasia M; Paţiu IM; Vlăduţiu D; Barabas E; Spânu C; Căprioară M
    Endocrinologie; 1981; 19(4):253-6. PubMed ID: 7323650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patch-clamp study on T-lymphocyte potassium conductance in patients with chronic renal failure.
    Teisseyre A; Zmonarski SC; Klinger M; Mozrzymas JW; Miekisz S
    Nephron; 1996; 72(4):587-94. PubMed ID: 8730426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
    Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
    Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor I values in patients on maintenance hemodialysis: relationship to growth hormone and albumin levels.
    Caufriez A; Abramowicz D; Vanherweghem JL; Copinschi G
    J Endocrinol Invest; 1993 Oct; 16(9):691-6. PubMed ID: 8282965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.